Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates
Zai Lab Limited - American Depositary Shares (ZLAB)
US:NASDAQ Investor Relations:
zailaboratory.com/about/investors.php
Company Research
Source: Business Wire
– Zocilurtatug pelitecan (zoci, DLL3 ADC) (formerly ZL-1310) data presented at Triple Meeting in October continues to demonstrate first- and best-in-class potential, supporting the recent initiation of the global registrational study in 2L+ ES-SCLC– Advancing other high-potential global programs, including initiation of a global Phase 1 study for ZL-1503 (IL-13xIL-31R bispecific antibody) and a planned IND submission for ZL-6201 (LRRC15 ADC) by year-end 2025– KarXT was recently included in China’s national-level treatment guidelines, underscoring the urgent need for novel therapies in schizophrenia; launch preparations are underway– Total revenues grew 14% y-o-y to $116.1 million in the third quarter of 2025, operating loss improved by 28% y-o-y to $48.8 million, and by 42% to $28.0 million on an adjusted basis1; revising total revenue guidance for the full year 2025 to at least $460 millionConference call and webcast today, November 6, 2025, at 8:00 a.m. ET (9:00 p.m. HKT) SHANGHA
Show less
Read more
Impact Snapshot
Event Time:
ZLAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZLAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZLAB alerts
High impacting Zai Lab Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
ZLAB
News
- Zai Lab (ZLAB) Remains a Buy Amid Strong Commercial and Pipeline Momentum [Yahoo! Finance]Yahoo! Finance
- Zai Lab Limited: Declining Despite Making Progress - I See Opportunity (Reiterate Buy) [Seeking Alpha]Seeking Alpha
- Zai Lab Limited (ZLAB) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Zai Lab Non-GAAP EPS of -$0.33 misses by $0.04, revenue of $116.09M misses by $27.64M [Seeking Alpha]Seeking Alpha
- Zai Lab Announces Participation in Investor Conferences in November and December 2025Business Wire
ZLAB
Earnings
- 11/6/25 - Miss
ZLAB
Sec Filings
- 11/25/25 - Form 4
- 11/21/25 - Form 144
- 11/14/25 - Form SCHEDULE
- ZLAB's page on the SEC website